Clinical Trial Update: Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced-intensity conditioning donor stem cell transplantation for relapsed multiple myeloma has been terminated; results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Donor stem cell transplant with reduced-intensity conditioning

Snippet

Sponsor: Srinivas Devarakonda | Conditions: Recurrent Plasma Cell Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-09-28